Login / Signup

Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium.

Anissa MessaaouiLucia HajselovaSylvie Tenoutasse
Published in: Journal of pediatric endocrinology & metabolism : JPEM (2021)
The prevalence of anti-SARS-CoV-2 antibodies in children with newly diagnosed type 1 diabetes (20%) is similar to that found in children without diabetes in Belgium, a country severely affected by this pandemic.
Keyphrases
  • sars cov
  • type diabetes
  • young adults
  • respiratory syndrome coronavirus
  • newly diagnosed
  • glycemic control
  • coronavirus disease
  • risk factors
  • insulin resistance
  • metabolic syndrome
  • adipose tissue